Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 146,930 | 197,673 | -28,239 | -65,904 | -71,648 |
| Depreciation Amortization | 8,670 | 8,853 | 10,783 | 9,372 | 7,250 |
| Income taxes - deferred | 11,020 | -84,280 | 0 | N/A | N/A |
| Accounts receivable | -108,430 | -22,578 | -11,916 | 13,072 | -15,340 |
| Accounts payable and accrued liabilities | 2,330 | 4,150 | 3,839 | 800 | 1,356 |
| Other Working Capital | -139,595 | -18,539 | -10,123 | -18,286 | -51,680 |
| Other Operating Activity | 129,471 | 33,393 | 44,456 | 1,438 | 17,693 |
| Operating Cash Flow | $50,396 | $118,672 | $8,800 | $-59,508 | $-112,369 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22,575 | -8,226 | -4,771 | -13,911 | -13,511 |
| Purchase Sale Intangibles | -316 | -349 | -210 | N/A | N/A |
| Other Investing Activity | 684 | -349 | -210 | 0 | 0 |
| Investing Cash Flow | $-21,891 | $-8,575 | $-4,981 | $-13,911 | $-13,511 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 105,000 | 0 | 135,000 | 151,750 | N/A |
| Debt Repayment | -108,282 | -60,825 | -171,327 | -102,036 | -34 |
| Common Stock Issued | 2,984 | 7,494 | 1,104 | 64,820 | 121,144 |
| Common Stock Repurchased | -31,940 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -11,784 | -4,971 | -3,766 | -5,682 | -62 |
| Financing Cash Flow | $-44,022 | $-58,302 | $-38,989 | $108,852 | $121,048 |
| Beginning Cash Position | 103,147 | 51,352 | 86,522 | 51,089 | 55,921 |
| End Cash Position | 87,630 | 103,147 | 51,352 | 86,522 | 51,089 |
| Net Cash Flow | $-15,517 | $51,795 | $-35,170 | $35,433 | $-4,832 |
| Free Cash Flow | |||||
| Operating Cash Flow | 50,396 | 118,672 | 8,800 | -59,508 | -112,369 |
| Capital Expenditure | -22,575 | -8,226 | -4,771 | -13,911 | -13,511 |
| Free Cash Flow | 27,821 | 110,446 | 4,029 | -73,419 | -125,880 |